Selected article for: "high level and previous vaccination"

Author: Konstantinidis, T.; Zisaki, S.; Mitroulis, I.; Konstantinidou, E.; Kontekaki, E. G.; Romanidou, G.; Karvelas, A.; Nanousi, I.; Lazidis, L.; Cassimos, D.; Tsigalou, C.; Martinis, G.; Panopoulou, M.
Title: Levels of produced antibodies after vaccination with mRNA vaccine; effect of previous infection with SARS-CoV-2
  • Cord-id: rfjcggeo
  • Document date: 2021_4_7
  • ID: rfjcggeo
    Snippet: The aim of this study was to estimate the immunogenic effect of mRNA vaccine against SARS-CoV-2. This study included 510 participants who received mRNA vaccine. The measurement of anti-Covid-19 antibodies was performed using the Abbott SARS-CoV-2 IgG quantitative assay (Abbott). Overall, mean title of anti-Spike antibodies was 19319.2+/-1787.5 AU/ml. Vaccination induced a robust immunogenic response in previous infected with SARS-CoV-2 compared. Additionally, individuals that were asymptomatic a
    Document: The aim of this study was to estimate the immunogenic effect of mRNA vaccine against SARS-CoV-2. This study included 510 participants who received mRNA vaccine. The measurement of anti-Covid-19 antibodies was performed using the Abbott SARS-CoV-2 IgG quantitative assay (Abbott). Overall, mean title of anti-Spike antibodies was 19319.2+/-1787.5 AU/ml. Vaccination induced a robust immunogenic response in previous infected with SARS-CoV-2 compared. Additionally, individuals that were asymptomatic after vaccination produced lower levels of antibodies compared to feverish individuals. In conclusion, remarkable high level of anti-Spike Covid-19 antibodies was found after vaccination

    Search related documents:
    Co phrase search for related documents